Influences of Multivitamin Supplementation on Health Parameters
NCT ID: NCT03071796
Last Updated: 2017-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2017-03-07
2017-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Everyday Functioning in Adults Aged 70 and Over Using a Multivitamin Supplement
NCT04112732
Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Indices of Human Health
NCT03146312
The Effects of a Nutrition Supplement on Health Related Quality of Life
NCT04499560
Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule)
NCT03146273
Oral Nutritional Supplement Effect on HDL Function
NCT04529174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigator aims to determine the effects of multivitamin supplement on blood and vital parameters which includes blood pressure, pulse, heart rate, variability of heart rate, vitamin D, vitamin B12, folic acid, homocysteine, HbA1c. Furthermore the investigator will access life quality, mood and perception of stress through the following questionnaire POMS, PSS-10, SF12 \& SF36. The investigator will evaluate whether the multivitamin supplement changes the frequency of diseases like cold which represents the function of the immune system.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
multivitamin supplement
liquid multivitamin supplement for 12 weeks
multivitamin supplement
supplement includes 97 natural extracts
placebo
liquids with similar appearance and taste like multivitamin supplement for 12 weeks
Placebo
liquids with similar appearance and taste like multivitamin supplement for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
multivitamin supplement
supplement includes 97 natural extracts
Placebo
liquids with similar appearance and taste like multivitamin supplement for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 30-60 years
* employed
Exclusion Criteria
* frequent use of alcohol, drugs or cigarettes (\>5 cigarettes / day)
* use of additional supplements
* use of medications (e.g. antihypertensive medications, lipid reducers, thyroid medication)
30 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Martin-Luther-Universität Halle-Wittenberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kuno Hottenrott, Prof.
Prof. Dr.; University of Halle-Wittenberg, Department of Sports
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kuno Hottenrott, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Halle-Wittenberg, Department of Sports
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Halle-Wittenberg
Halle, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILUG-201701
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.